MRVI

Maravai LifeSciences Stock Price

36.39
0.93 (2.62%)
Upgrade to Real-Time
Regular Market
36.39

Low
23.62

52 Week Range

High
40.24

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Maravai LifeSciences Holdings Inc MRVI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.93 2.62% 36.39 10:45:57
Open Price Low Price High Price Close Price Prev Close
35.42 35.105 36.53 35.46
Bid Price Ask Price Spread News
36.36 36.46 0.10 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,020 81,117 $ 35.92 $ 2,913,939 1,299,715 23.62 - 40.24
Last Trade Time Type Quantity Stock Price Currency
10:45:57 1 $ 36.46 USD

Maravai LifeSciences Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.37B 257.62M 67.68M $ 143.14M $ 49.58M -0.02 137.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Maravai LifeSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRVI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week37.0537.5534.8536.331,194,498-0.66-1.78%
1 Month33.7838.58531.2934.641,739,7012.617.73%
3 Months29.96540.2428.0935.021,470,0996.4321.44%
6 Months31.1140.2423.6232.061,457,4335.2816.97%
1 Year31.1140.2423.6232.061,457,4335.2816.97%
3 Years31.1140.2423.6232.061,457,4335.2816.97%
5 Years31.1140.2423.6232.061,457,4335.2816.97%

Maravai LifeSciences Description

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.


Your Recent History
NASDAQ
MRVI
Maravai Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.